Vext Science, Inc. (VEXT) Earnings Call Transcripts

Vext Science, Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Vext Science, Inc. reported a revenue increase of 5% year-over-year to $12.2 million, driven primarily by a 34% rise in Ohio revenue, which reached $8.2 million. The company achieved a gross profit of $5.5 million, more than doubling from the prior year, and an adjusted EBITDA of $3.6 million, reflecting a margin of 29%. Management signaled a focus on expanding operations in Ohio while streamlining Arizona operations, indicating a strategic pivot that could enhance profitability moving forward.

Reported metrics

Guidance from management

Management expects to complete the Arizona cultivation exit by the end of Q2 2026, with full cash flow benefits anticipated in Q3. They remain focused on expanding operations in Ohio and improving cash flow generation.

What management said

Good morning, Pablo. So the same thing that's been challenging on getting our retail stores open is the weather being too cold to pour concrete and too rainy to draw lines on the concrete. The same thing that's going to protect the cultivation investments.

Yes. I would say I hate to use this word, stable pricing around $400 to $500 a pound. But we're not the only operator suffering from the overproduction, and we'll continue to be opportunistic on finding deals sub-$400, which are out there. We're currently sourcing and frankly, expect to be able to source for the foreseeable future.

What analysts pressed on

Analysts expressed concerns regarding the competitive landscape in Ohio and potential pricing pressures as more dispensaries open. There were also questions about the timing and impact of tax liabilities on future cash flows.

Main topics on the call

• Ohio Revenue Growth — Ohio revenue surged 34% year-over-year to $8.2 million, attributed to the performance of newly acquired dispensaries and improved cultivation. Management noted, 'Ohio continues to be the primary growth driver for Vext.'
• Arizona Market Challenges — Arizona revenue declined 24% due to oversupply and pricing pressure, with wholesale revenue down approximately 50%. Management stated, 'The Arizona wholesale market is oversupplied and prices have compressed.'
• Improved Profitability Metrics — Gross profit increased to $5.5 million, representing a margin of 45.4%, up from 19.7% in the prior year. Adjusted EBITDA was $3.6 million, indicating a margin of 29%, showcasing improved operational efficiency.
• Cash Flow Generation — Operating cash flow was reported at $1.6 million, reflecting a cash flow margin of 13%. Management emphasized, 'Operating cash flow remains one of the clearest indications that our strategy is working.'

Read the full Vext Science, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 16 Vext Science, Inc. earnings call transcripts on record, spanning April 20, 2022 to May 21, 2026. Based on this history, Vext Science, Inc. reports quarterly. The most recent call on file is dated May 21, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

VEXT

Exchange

CNSX

Country

CA

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

16

First call

April 20, 2022

Most recent

May 21, 2026

Reporting cadence

quarterly